Affordability of new HIV treatments.

Subjects

Subjects :

Drug Costs
HIV Infections economics
HIV Integrase Inhibitors therapeutic use
Heterocyclic Compounds, 3-Ring therapeutic use
Humans
Oxazines
Piperazines
Pyridones
HIV Infections drug therapy
HIV Integrase Inhibitors economics
Heterocyclic Compounds, 3-Ring economics

Details

Language :

English

ISSN :

1474-547X

Volume :

384

Issue :

9946

Database :

MEDLINE

Journal :

Lancet (London, England)

Publication Type :

Editorial & Opinion

Accession number :

25209483

Full Text :

https://doi.org/10.1016/S0140-6736(14)61484-7